Matthew B. Klein Ptc Therapeutics, Inc. (PTCT) insider trading activity
Matthew B. Klein is CHIEF EXECUTIVE OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 337,767 shares of PTCT, which is worth approximately $15.3 Million. The most recent transaction as insider was on Apr 20, 2021, when has been sold 1,641 shares (Common Stock) at a price of $47.25 per share, resulting in proceeds of $77,537. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
338K
23.62%
3M change
49.58%
12M change
Total Value Held
$15.3 Million
Matthew B. Klein Transaction History
Also insider at
MBK
Matthew B. Klein
CHIEF EXECUTIVE OFFICER
South Plainfield, NJ